Natural progression of aortic stenosis in a veteran population by Alabre, Marjory
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1998




Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Alabre, Marjory, "Natural progression of aortic stenosis in a veteran population" (1998). Yale Medicine Thesis Digital Library. 2329.
http://elischolar.library.yale.edu/ymtdl/2329






Permission to photocopy or microfilm processing 
of this thesis for the purpose of individual 
scholarly consultation or reference is hereby 
granted by the author. This permission is not to be 
interpreted as affecting publication of this work or 
otherwise placing it in the public domain, and the 
author reserves all rights of ownership guaranteed 
under common law protection of unpublished 
manuscripts. 
Digitized by the Internet Archive 
in 2017 with funding from 




NATURAL PROGRESSION OF AORTIC STENOSIS IN A 
VETERAN POPULATION 
A Thesis submitted to the Yale University School of Medicine in 






YUll pn?n/»! WftRY 
AUG 1 3 19.98 
ACKNOWLEDGEMENTS 
I would like to express my gratitude to Dr. Ezekowitz for providing me 
with this project and guiding me through it. 
I would also like to thank Dr. Cohen for allowing me to use his 
database and giving me his time and advice when I needed them. 
A special thank you to Dr. Viola Vaccarino and John Holahan for their 
assistance with the statistical analyses. 
Also, I want to take this opportunity to thank my parents, Gilbert and 
Marie Anne Alabre, for teaching me to always believe in myself. Their 
unwavering support, constant encouragement, and unconditional love have 
given me the freedom to go after my dreams. No child could ask for better 
parents and I thank God for them. 
To my siblings, Wilherm, Germain, Sherley, Vaner, Rither, Menes 
Junior, Anne Gilberte and Gilbert Junior, I want to say "THANK YOU". They 
have all contributed, each in his/her special way, to making me the person 
that I am today. I love them all. 
Lastly, I want to thank Richard Lyn-Cook for his diligence during the 
writing of this thesis, his proof-reading skills which he so generously lent me, 
and his continuous support. 

TABLE OF CONTENTS 
I. ABSTRACT 
II. INTRODUCTION 1 
A. Definition 1 
B. Prevalence 1 
C. Etiology 3 
D. Pathophysiology 11 
E. Diagnosis 15 
1. Bedside 15 
2. Non-Invasive 16 
3. Invasive 29 
F. Timing of Surgery 20 
G. Rate of Progression of the Disease 22 
H. Conclusion 25 
III. STUDY QUESTION 25 
IV. METHODS 25 
A. Patient Population 25 
B. Data Analysis 26 
1. AVA Group 27 
2. Peak AV Gradient Group 28 
V. RESULTS 28 
A. AVA Group 28 
B. Peak AV Gradient Group 30 
VI. DISCUSSION 32 
A. Major Findings 32 
B. AVA Group 32 
1. Overall Results 32 
2. Individual Risk Factors 33 
a. History of HTN 33 
b. Smoking 34 
c. Serum Lipids 34 
d. Diabetes 35 
C. Peak AV Gradient Group 35 
1. Overall Results 35 
D. Rate of Progression 36 
E. Limitations 
1. Reliability of Measuring Valve Area and 
39 
Gradient 39 
2. Sample size 40 

VII. TABLES AND FIGURE 42 
Table A. Effect of Diabetes upon Risk of Aortic 
Stenosis, according to Age Group 42 
Table B. Effect of Elypercholesterolemia upon 
Risk of Aortic Stenosis, according to 
Age Group 43 
Figure 1. Changes of Echocardiographic Parameters 
during Follow-Up in two Patients with 
Severe Aortic Stenosis but Normal Left 
Ventricular Wall Thickness 44 
Table 1. Comparison between Patients with Decrease 
in AVA and those without Decrease according 
to Risk Factors 45 
Table 2. Mean AVA Decrease in Patients according to 
Presence or Absence of Risk Factors 46 
Table 3. Two-Tailed t Values, p Values and Correlation 
Coefficients in Patients with AVA Decrease 
according to Risk Factors 47 
Table 4. Two-tailed t Values, p Values and Correlation 
Coefficients in Patients with AVA Decrease 
According to the Number of Risk Factors 48 
Table 5 Comparison between Patients with Increase in 
Peak AV Gradient and those without Increase 
according to Risk Factors 49 
Table 6 Mean Peak AV Gradient Increase in Patients 
according to Presence or Absence of Risk 
Factors 50 
Table 7 Two-Tailed t Values, p Values and Correlation 
Coefficients in Patients with Peak AV Gradient 
Increase according to Risk Factors 51 
Table 8 Two-Tailed t Values, p Values and Correlation 
Coefficients in Patients with Peak AV Gradient 
Increase according to the Number of Risk 
Factors 52 
Table 9 Mean AVA Decrease in Patients according to 
the number of Risk Factors Present 53 
Table 10 Mean Peak AV Gradient Increase in Patients 
according to the Number of Risk Factors 
Present 54 
VIII. REFERENCE 55 

I. ABSTRACT 
NATURAL PROGRESSION OF AORTIC STENOSIS IN A VETERAN 
POPULATION. Marjory Alabre and Michael Ezekowitz, Section of 
Cardiology, Department of Internal Medicine, Yale University School of 
Medicine, New Elaven, Connecticut. 
To try to determine the rate of progression of aortic stenosis (AS) and 
the factors which can help predict its rate of progression, we looked at 109 
patients with varying degrees of the disease, selected from the echo lab at the 
West Haven VA Medical Center. We studied them retrospectively and 
prospectively with respect to 9 risk factors: history of hypertension, smoking, 
cholesterol level>200, HDL<29, triglyceride level>160, NIDDM, IDDM, 
BUN>40, and creatinine>2. Data was collected from their echo charts, medical 
charts, and their computerized lab values. We then divided them into two 
groups depending on whether we were looking at the area under the aortic 
valve (AVA) or the peak aortoventricular (AV) gradient in order to 
determine progression. The groups comprised 32 and 69 patients, respectively 
(only patients who had had more than one measurement of the parameter 
under consideration qualified for inclusion). Next, t values, p values and 

II 
correlation coefficients were determined for the different factors studied, as 
well as different combinations of factors. Finally, a multiple regression 
analysis was carried out on all 32 patients in the AVA group. 
Of the 32 patients in the AVA group, 21 (65.6%) were found to have 
progression of the disease, evidenced by a decrease in the AVA, over an 
average observation period of 15 months ±6(1 SD). Fifty eight (84%) of the 69 
patients in the peak AV gradient group showed progression, demonstrated by 
an increase in the gradient, over an average of 4.6 years ± 2 (1 SD). The rates 
2 
of progression were 0.35 cm /year ± 0.22 (1 SD) for the AV group and 6 
mmHg/year ± 5.5 (1 SD) for the gradient group. The presence of a history of 
hypertension, smoking, cholesterol level>200, triglyceride level>160, NIDDM, 
and any two risk factors together were associated with a greater mean AVA 
decrease. Those results, however, were not statistically significant (p=NS). 
On the other hand, only a history of hypertension and NIDDM were 
associated with a greater mean peak AV gradient increase. Again, statistical 
analyses showed no significance (p=NS). Furthermore, multiple regression 
analysis also failed to show any statistical significance (p=NS). 
We conclude that the rate of progression of aortic stenosis in this 
2 
population was 0.35 cnV/year ± 0.22 (1 SD) as measured by the AVA and 6 
mmHg/year ± 5.5 (1 SD) as measured by the peak AV gradient. Although a 

history of hypertension, smoking, cholesterol>200, triglyceride>160 and 
NIDDM seemed to be associated with a greater rate of AS progression, the 
associations were not statistically significant. Lastly, we discuss the 





Valvular aortic stenosis is characterized by narrowing of the lumen of the 
ventriculoaortic opening and is especially common in the older population. 
There is a long period of low risk when patients are asymptomatic but once 
symptoms develop, their prognosis worsens tremendously. Aortic valve 
replacement usually improves symptoms and prolongs survival. However, in 
patients who do not undergo surgery, survival depends on the nature of the 
symptoms: 3 years after the onset of angina or syncope, 2 years after that of 
50 
dyspnea, and 1.5 to 2 years after that of congestive heart failure. In general, 
33 
without surgery, adults have an average mortality rate of 9% per year. 
Valvular aortic stenosis is only one of various forms of left ventricular outflow 
obstruction; others include supravalvular aortic stenosis where the narrowing is 
distal to the aortic cusps, and subvalvular aortic stenosis with the obstruction 




The prevalence of valvular aortic stenosis varies with the population 
37 
studied. The Helsinki Ageing Study'- (discussed elsewhere in this paper) 
evaluated a random sample of patients between the ages of 75 and 86, and found 
that 5% had at least moderate valvular aortic stenosis while 3% had severe 
valvular aortic stenosis. When the latter population was divided into cohorts of 
smaller age range, the prevalence varied from 1% to 2% in patients aged 75 to 76 
years to almost 6% in those who were 85 to 86 years old. In that study, the 
stenosis was considered moderate if the aortic valve area was <1.2 cm2 but > 0.8 
cm2. It was considered severe if the valve area was < 0.8 cm2 and the velocity 
ratio (VmaxLVOT/VmaxAV) < 0.35 or if the patient had undergone surgery during 
old age as a result of aortic valve stenosis. Furthermore, they also looked at 
37 
patients between the ages of 55 and 71 and found no cases of aortic stenosis." 
Another study by Aronow and Kronzon- prospectively investigated 781 
unselected patients between the ages of 62 and 100 (558 women and 223 men) in 
a long-term health care facility. They demonstrated the prevalence of mild (peak 
aortic flow velocity=l.6-2.5 m/s or peak gradient=10-25 mmHg), moderate (peak 
aortic flow velocity=2.6-3.5 m/s or peak gradient=26-49 mmHg), and severe 
(peak aortic flow velocity>3.6 m/s or peak gradient>50 mmHg) aortic stenosis to 




Valvular aortic stenosis in adults is either congenital or acquired. When 
congenital, the aortic valve may be unicuspid or bicuspid and when acquired, 
may be tricuspid.40 While the congenital form of the disease usually manifests 
anywhere from the neonatal period to late adulthood, acquired aortic stenosis is 
49 
most prevalent in the elderly. In a study which evaluated 188 patients over 40 
years of age (26% women and 74% men) who had undergone aortic valve 
replacement because of severe stenosis and which consisted of only 29% of 
patients over age 65, Mautner et al. found that 62% of the patients had either a 
unicuspid or a bicuspid aortic valve while the remainder (38%) had a tricuspid 
40 
valve. 
Acquired aortic stenosis can be divided into two types: valvular aortic 
stenosis due to degenerative changes, and valvular stenosis resulting from 
rheumatic diseases. Over the past few decades, there has been a decline in the 
prevalence of rheumatic heart disease. Thus the major cause of aortic stenosis 
52 
has shifted from rheumatic to non rheumatic. 
Degenerative valvular aortic stenosis is characterized by focal fibrosis, 
lipidosis and calcification of the leaflets on the aortic side of the valve. The 
calcific lesions form a nodular ridge that is attached to the annulus, thereby 

4 
preventing the free motion of the annulocuspid junction. This process leads to 
cusp rigidity and the development of stenosis. At times, the cusps may become 
fixed in a semi-open position, leading to aortic regurgitation with or without 
concurrent aortic stenosis. Consequently, the valvular opening looks like a 
25 
triangle whose sides bow inward. Fusion of the commissures is very rare and 
when present, is only minimal. 
On the other hand, aortic stenosis due to rheumatic fever is characterized 
by a valve that grossly looks "as though white candle wax had been poured over 
it". Furthermore, the cusp fibrosis is diffuse rather than focal and is associated 
with cusp rigidity and commissural fusion, both of which eventually lead to 
valvular stenosis. In general, the degree of aortic stenosis and the number of 
fused commissures are directly proportional. Usually cusp motion is further 
compromised by the formation of secondary calcification on the aortic and the 
25 
ventricular sides of such valves. 
Even though the prevalence of degenerative valvular aortic stenosis 
clearly increases with age and aging brings changes to the valve leaflets, the 
absence of degenerative aortic stenosis (AS) in a large number of elderly 
37 
individuals makes it unlikely to be an inevitable consequence ot aging. Rather, 
it appears to be a "tissue response to some initiating factor" as evidenced by Otto 
45 
et al in a study of 27 aortic valves. Taken at autopsy from adults between the 

5 
ages of 46 and 82, 6 of the valves were normal, 15 had mild macroscopic leaflet 
thickening, and 6 were from adults who had had clinical AS. Histological and 
immunohistochemical studies of the normal valves found scattered macrophages 
in the fibrosa and ventricularis, occasional muscle actin-positive cell in the 
ventricularis near the leaflet base, but no T lymphocytes. On the contrary, "early 
lesions" (evidenced by focal areas of thickening) were characterized by an 
inflammatory infiltrate made of non-foam cell and foam cell macrophages, 
occasional T cells, and few a-actin-positive cells. Stenotic valves had similar, 
although more advanced, lesions. They concluded that early degenerative AS is 
an active inflammatory process which presents some similarities (lipid 
deposition, macrophage and T-cell infiltration, and disruption of basement 
membrane) and some dissimilarities (prominent mineralization and few smooth 
muscle cells) to atherosclerosis. 
This study raised questions concerning the regulation of the inflammatory 
43 
process. O'Brien et al " investigated the presence of osteopontin, a protein 
known to be implicated in the regulation of normal as well as dystrophic 
calcification, in valvular aortic stenotic lesions. They evaluated 14 human aortic 
valves, ranging from morphologically normal to clinically stenotic, and 
concluded that osteopontin was present in both the early and late lesions of AS. 
They found highly statistically significant correlations between the amount of 

6 
osteopontin present and both the degree of calcification and the infiltration of 
macrophages. Lastly, they were able to demonstrate, by in situ hybridization, 
that a subset of lesion macrophages were actively producing osteopontin. 
O'Brien et al proposed that those results are compatible with the hypothesis that 
rather than being a degenerative and unmodifiable process, calcification of the 
aortic valve is, at least partly, an active process which requires the presence of 
inflammatory cells. 
In light of the demonstrated presence of macrophages and T lymphocytes, 
two chronic inflammatory cells, in the lesions of AS and the fact that lipoprotein 
deposition is prominent in atherosclerosis, a known chronic inflammatory 
44 
process, O'Brien et al proposed that lipoprotein may also be present in aortic 
valve lesions. They looked at human aortic valvular tissue from autopsy 
specimens (n=15) and surgical specimens (n=3) from a total of 18 patients (tissue 
from those patients had been used in the study previously mentioned). Fifteen 
of the valves were either normal or mildly thickened (morphologically early 
disease). The remaining 3 valves were severely thickened and in those patients 
had shown clinical evidence of being severely obstructed. The results of the 
study were consistent with the hypothesis formulated. The accumulation of 
three apolipoproteins, namely apoB, apo(a), and apoE was demonstrated in AS 

7 
valvular lesions. Furthermore, prominent calcium deposition was observed in 
many areas of apolipoprotein accumulation. 
The degree of calcification of the aortic valve varies for reasons that are 
24 
unknown. Edwards argues that, regardless of its etiology, AS is really the 
result of trauma to the leaflets. That trauma may be caused by either rheumatic 
disease, abnormal stress response from a bicuspid valve, or many years of 
normal function as in the case of a tricuspid valve. The latter is referred to as the 
"wear and tear" hypothesis. Functionally and histologically, the aortic valve is 
constructed so that mechanical stress is shared between the three leaflets and the 
sinuses of Valsalva. Over the years, however, the continuous stress of 
opening and closing takes its toll and the valve is injured. This hypothesis is 
supported by the observation that patterns of calcification correspond to sites of 
55 56 
increased mechanical stress ' and that congenital bicuspid valves, which 
would be assumed to share stress less effectively, become diseased earlier and 
4 
have more rapid progression of their stenosis. 
Other factors that contribute to the development of AS include diabetes 
21 32 
and hypercholesterolemia, but their role remains an area of dispute. 
21 
Deutscher et al. looked at the relationship between these two factors and aortic 
stenosis in a retrospective study of 54 patients (between the ages of 40 and 87) 
with isolated AS who were undergoing cardiac catheterization; 461 patients 

without AS who were having cardiac catheterization for other reasons were 
used as controls. They found odds ratios estimates greater than 2 for patients 
older than 50 but only approximately 1 for patients under the age of 50 (Table A) 
suggesting that there may be an age-dependent association between diabetes and 
“calcific aortic stenosis". The results held even when a subset of patients without 
coronary artery disease was evaluated. Hypercholesterolemia, defined as a 
cholesterol level > 300 mg/100 ml, was also associated with aortic stenosis (Table 
B). On the other hand, in an attempt to analyze whether atherosclerotic risk 
factors such as systemic hypertension, hypercholesterolemia, smoking, and 
32 
diabetes were associated with the presence of aortic stenosis, Hoagland et ah" 
evaluated 105 patients, aged 50 or older, with presumed nonrheumatic aortic 
stenosis but no coronary artery disease, and compared them with 3 different 
control groups (Total=549 patients). When the control groups were combined, 
they found no statistically significant association between any of the risk factors 
and AS. The strongest association pertained to cigarette smoking (risk ratio=1.5) 
but the significance was marginal (p=0.06). All the above data, however, are 
38 
based on small studies where the patients belonged to highly selected groups. 
In a study of unselected elderly people who participated in the Helsinki 
Ageing Study, a study conducted in the city of Helsinki to determine whether 




factors involved in calcium metabolism, nine hundred people, born in 1904, 
1909 and 1914 were originally sampled at random. By the time the survey 
started, 399 people did not participate due to either death, loss of contact, or 
unwillingness. In addition, 80 people born in 1920, 1925, 1930 and 1935 were 
randomly selected to join the study, but 4 of them declined. Of the 577 final 
subjects, complete ultrasound evaluation of the aortic valve was performed in 96 
percent of them. They found age, hypertension, body mass index and high 
serum parathyroid hormone to be associated with valve calcification. Aside from 
age and hypertension, the traditional risk factors for atherosclerosis had no 
influence on the extent of aortic valve calcification. However, the concentrations 
of parathyroid hormone and ionized calcium were found to be associated with 
the degree of calcification and stenosis of the aortic valve, respectively. These 
results indicate an association between the metabolism of calcium and aortic 
valve calcification, but the mechanism of this association remains to be 
determined. The inverse relationship between body mass and aortic valve 
calcification was independent of age. Furthermore, it was found that gender, 
diabetes, serum lipids and smoking were unrelated to aortic valve calcification. 
We must point out that the above associations are statistical associations and do 
38 




Another study which looked at factors that could predict the structure 
(i.e., the number of cusps present) of the stenotic aortic valve, and therefore the 
origin of the stenosis, found the following 4 factors to be significant: age, total 
serum cholesterol, body mass index and coronary artery disease. Patients with 
high values for or presence of 3 or all 4 factors (namely age>65 years, total serum 
2 
chol>200 mg/dl, body mass index>29 kg/m and coronary artery disease) had a 
low probability of having a congenitally malformed valve. On the other hand, 
patients with low values for or absence of 3 or all 4 factors (namely age<65 years, 
2 
total serum chol<200 mg/dl, body mass index<29 kg/m“ and no coronary artery 
disease) had a high probability of having a stenotic valve whose origin was 
congenital. Furthermore, age was the strongest predictor and coronary artery 
disease the least significant. 
In conclusion, the specific etiology of "degenerative" or "calcific" aortic 
stenosis has not been established categorically. Certainly, the old assumption 
that it is an inevitable consequence of old age has been challenged with recent 
43-45 
evidences suggesting an inflammatory process. ^ " Since inflammation is not 
an initiating event, but rather a response to some kind of insult, the question rises 
as to what might constitute an insult to the normal tricuspid aortic valve. The 
concept of "wear and tear", meaning repeated years of opening and closing 
4,55-56 
causing trauma to the valve, is one that has been widely supported. 

However, since not all elderly people develop the disease, there must be more 
involved in the process. Factors such as diabetes, hypercholesterolemia, systemic 
hypertension, smoking and coronary artery disease may just be the other 
unknowns of the equation. Unfortunately, studies to date have not been 
successful at establishing definite causal relationships. More and larger studies 
are therefore needed. 
D. PATHOPHYSIOLOGY 
The obstruction to the left ventricular flow alters the hemodynamics in the 
left ventricle by creating a pressure overload. To maintain adequate cardiac 
output, the left ventricle's systolic pressure elevates and the ejection time 
increases. Progressively, the left ventricle hypertrophies without cavity 
enlargement ("concentric hypertrophy"), a compensatory mechanism whose 
effectiveness varies with the adequacy of the thickening. Both the 
interventricular septum and the posterior wall have a normal thickness of up to 
12 mm but in one patient with AS, they went up to 14 mm and 19 mm, 
46 
respectively. Therefore, left ventricular (LV) concentric hypertrophy 
27 
represents the major adaptive mechanism to valvular aortic stenosis. 
However, this compensation results in a reduced diastolic compliance and an 

2 
increased oxygen consumption, both of which eventually lead to congestive 
heart failure, myocardial ischemia and angina pectoris, all well known 
symptoms of valvular aortic stenosis. Although patients with severe aortic 
stenosis usually show "marked left ventricular hypertrophy and strain", the 
evidence of "borderline left ventricular hypertrophy" does not exclude the 
diagnosis. Older patients need a less severe stenosis for decompensation to take 
place. Consequently, the same degree of stenosis can be considered moderate in 
54 
a young patient and severe in an elderly patient. It is worth mentioning that 
not all patients with AS express increased transvalvular gradient. In fact, some 
patients present with the clinical syndrome of severe AS, a low mean gradient, 
20 
and left ventricular dysfunction. 
It has been documented that the progression of severity of aortic stenosis 
and an increase in left ventricular wall thickness usually coexist. However, 
27 
investigators have recently reported two cases of patients with severe aortic 
stenosis but normal thickness of the left ventricular wall. In one patient (patient 
1), an increase in the severity of the stenosis was seen with an increase in left 
ventricular dimensions, and a reduction in the thickness of the wall in addition to 
27 
systolic function (Figure 1). Also present, were symptoms of heart failure 
which worsened over time. Echocardiographic exams of the other patient 
(patient 2) confirmed these observations. Usually, in patients with aortic 

13 
stenosis, symptoms of congestive heart failure are indicative of poor left 
ventricular systolic function. However, heart failure is also seen in patients with 
intact systolic function. These cases have diastolic dysfunction of the left 
22 
ventricle. Recently, studies have shown that differences in the geometry of the 
left ventricle are directly related to ventricular performance. For example, 
patients with normal systolic function of the left ventricle have smaller left 
ventricle with thick walls while those with left ventricular systolic dysfunction 
28 
have larger left ventricle. It remains to be demonstrated whether the thinning 
of the left ventricular wall is the late stage in the remodeling of the ventricle in 
patients with AS, or a totally different response to a chronic state of pressure 
27 
overload. Nonetheless, Faggiano et al. believe that the changes in both the 
geometry and the function of the left ventricle seen in these patients may be the 
results of" excessive pressure afterload" as well as "structural abnormalities due 
35 
to long-term cardiac hypertrophy". These patients being males is a significant 
11 
fact since a recent study published by Carroll et al. showed sex-related 
differences in the resulted function of the left ventricle in patients with AS. 
The classical symptoms of valvular aortic stenosis are angina pectoris, 
dyspnea, and syncope with survival periods of 5, 2, and 3-4 years, respectively. 
Sudden death occurs in 3%-5% of asymptomatic patients and in 15%-20% of 
symptomatic patients. The reason asymptomatic patients may suddenly die is 

14 
because the normal opening area of the aortic valve, which is 3 to 4 cm2, may 
, 5 
decrease, without symptoms, to 0.75 cm'. Angina and syncope are more often 
seen in younger patients, while older patients usually present with heart 
54 
failure. 
Valvular aortic stenosis is usually associated with aortic regurgitation 
which gives rise to a murmur. A third heart sound or S3 gallop in patients with 
30 
valvular disease is usually seen as a sign of heart failure. It has also been 
36 
associated with other problems such as elevated atrial pressure and abnormal 
1 
ventricular function. The sound depends on three factors: atrial pressure, early 
29 
diastolic filling rate, and ventricular compliance. According to Folland et al, a 
third heart sound is not as prevalent in aortic stenosis patients (11%) as it is in 
patients with mitral regurgitation (46%) or aortic regurgitation (28%). In aortic 
stenosis patients with a third heart sound, the ejection fraction of the left 
ventricle was found to be much lower (p<0.001) and the pulmonary wedge 
pressure was higher (p<0.001). These associations were either less significant (as 
in the case of ejection fraction) or nonexistent (as in the case of pulmonary wedge 
pressure) in patients with mitral regurgitation and third heart sounds. 
Therefore, although S3 are uncommon in patients with aortic stenosis, its 
„ 29 





As already mentioned, angina pectoris, dyspnea, and syncope are the 
classical symptoms of aortic stenosis. In the elderly, however, the disease can be 
12 
without clinical signs or at least, until late in its course. Even in the presence of 
a murmur characteristic of AS, a patient may remain asymptomatic. Besides 
these cardiac symptoms, patients also experience non-cardiac symptoms such as 
fatigue. In a study of 41 patients, dyspnea was reported as the major cardiac 
12 
symptom while fatigue constituted the major non-cardiac symptom. The 
clinical diagnosis of AS in elderly patients is difficult since this population has a 
high prevalence of the degenerative type of AS and the changes in the vascular 
system due to old age alter the main clinical signs of the disease. Because the 
systolic blood pressure and the pulse pressure are generally higher in the elderly, 
39 
they can not be used as reliable diagnostic criteria. Furthermore, the systolic 
murmur heard in AS is less intense than in younger patients and, therefore, can 
7 
be mistaken for a murmur due to aortic sclerosis or mitral regurgitation. AS 
patients experience a fall in cardiac output, a condition which makes the murmur 
of AS softer or eliminates it altogether. Consequently, low cardiac output 




"occult AS". The clinical diagnosis of AS unfortunately has many flaws. One 
study reported that out of 8 patients with AS, only 3 were diagnosed clinically 
over a period of six months. It is very important that the diagnosis of AS be 
ruled out in patients with cardiac failure, since some drugs such as angiotensin¬ 
converting enzymes (ACE) inhibitors, while beneficial in the treatment of cardiac 
12 
failure, are contraindicated when AS is present. Thus, other methods of 
diagnosis are necessary. 
2. Non-Invasive 
Echocardiographic methods, which are tests that use ultrasound to 
examine the heart and report information as echoes (reflected sonic waves), have 
totally revolutionized cardiological investigations. Ultrasound has a frequency 
above that detected by humans (>20,000 cycles/sec). In medicine, frequencies 
greater than 1,000,000 cycles/sec are used and no biological side effects have 
been demonstrated so far. However, its efficacy is limited since it cannot 
penetrate lungs and bones. The accuracy of ultrasound interpretation is very 
26 
much dependent upon the quality of the examination. There exists three 
modes of echocardiography: the A-mode (A for amplitude), the B-mode (B for 
brightness) and the M-mode (M for motion). An M-mode allows recording of 
amplitude and rate of motion, but it gives a one-dimensional view of the heart. 

17 
Complementing the M-mode, however, is a two-dimensional echocardiographic 
technique called 2-D which permits a pie-shaped slice of the heart to be studied 
(B). M-mode and 2-D echocardiographic techniques are used to make the 
diagnosis of calcified or thickened aortic cusps or root. In the Helsinki Ageing 
Study, mentioned previously in this paper, calcification of the aortic valve was 
diagnosed by M-mode and 2-D echocardiography in 53% of patients between 55 
37 
and 86 years of age. M-mode and 2-D are also used to measure chamber 
dimensions, left ventricular end-diastolic and end-systolic volumes, LV ejection 
3 
fraction, and to determine global and local left ventricular wall motion. 
While the M-mode and the 2-D allow a qualitative diagnosis of aortic 
stenosis, they are not effective at providing quantitative data. For that, 
investigators turn to Doppler echocardiography. Three forms of Doppler 
interrogation are in use: pulse-wave (PW), color-flow (CF), and continuous wave 
(CW) Doppler. Of the three, CW is the only one that allows accurate 
measurement of very high frequencies, well above those encountered in patients 
26 
with AS. It is now the method of choice for getting hemodynamic information. 
It is used to measure blood flow and it can also measure the pressure gradient 
across the aortic valve, using a modified version of the Bernoulli equation. 
Furthermore, the area of a valve can be calculated, using the "continuity 
equation”, and combining Doppler principles for measuring blood flow and 

pressure gradient. Consequently, Doppler echocardiography allows the 
differentiation between aortic stenosis and aortic sclerosis, a distinction which is 
12 
not possible with M-mode and 2-D. Echocardiography can also determine the 
degree of severity of the stenosis. Severe aortic stenosis is usually diagnosed 
when the aortic valve area is < 0.7 cm2, or if the peak pressure gradient across the 
3 
valve is > than 50 mmHg. However, one cannot always rely on the 
transvalvular gradients since some patients with severe AS and left ventricular 
dysfunction have been known to present with low transvalvular gradients. One 
20 
study by deFilippi et al. used dobutamine echocardiography to try to 
overcome this diagnostic problem. It was found that dobutamine echo could 
determine three subsets of hemodynamics in patients with severe AS, low 
transvalvular gradients and LV dysfunction. Patients with fixed AS showed 
increased cardiac output and gradient across the valve but aortic valve area 
remained the same. Patients with relative AS had a constant gradient but an 
increased valve area. Lastly, patients without contractile reserve could not 
increase their cardiac output with dobutamine and were said to have an 
indeterminate AS. Therefore, dobutamine allows the differentiation of patients 
whose LV dysfunction is a consequence of critical AS from those whose 
dysfunction is due to an underlying cardiomyopathy, thereby identifying 
patients who are likely to benefit from aortic valve replacement. In addition, this 
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study showed that valve resistance is flow-dependent in patients with fixed AS, 
20 
whereas valve area is flow-dependent in those with relative AS. 
3. Invasive 
While non-invasive methods of diagnosing aortic stenosis are fairly recent, 
invasive methods using cardiac catheterization go further back in the history of 
AS and are still very much in use today. There have been studies done 
comparing the efficacy of non-invasive and invasive diagnostic techniques. Shah 
53 
and Graham reported a greater than 95% agreement between Doppler 
echocardiography and cardiac catheterization when used to quantify the severity 
of AS. When the peak jet velocity was > 4.5 m/s in a patient, he/she was 
considered to have severe AS. If Doppler echocardiography shows peak jet 
velocity between 3.6 and 4.4 m/s in older patients who have cardiac symptoms 
due to AS, they should undergo cardiac catheterization. Older patients with a 
peak jet velocity anywhere from 3.0 to 3.5 m/s and a less than 50% left 
ventricular ejection fraction, may have severe AS and should be given a cardiac 
catheterization. Lastly, older patients who have a peak jet velocity between 3.0 
and 3.5 m/s but whose LV ejection is > 50%, should be subjected to cardiac 
53 
catheterization providing they have symptoms indicative of AS. Cardiac 

20 
catheterization is therefore, sometimes, used as a confirmatory technique after 
Doppler echocardiography has been used as the primary diagnostic tool. 
While Doppler echocardiography uses the continuity equation to measure 
aortic valve area, invasive techniques use what is called the Gorlin equation to 
31 
the same end. Gorlin valve area has been seen to change in in vitro models 
10,51 
using fixed orifice areas. This has been explained by the fact that the Gorlin 
equation uses a discharge coefficient which is susceptible to volume flow- 
51 
mediated variability. There exists a linear relationship between the 
9 
transvalvular volume flow rate and the valve area calculated by this equation. 
The continuity equation and the Gorlin equation are based on similar 
31 
hydrodynamic principles and recently, it has been demonstrated that the 
continuity equation also is dependent on transvalvular volume flow rate in 
9 
valvular AS. 
F. TIMING OF SURGERY 
Surgery is recommended for patients with symptoms of severe AS. 
Replacement of the aortic valve may be beneficial even to patients with severe 
59 
left ventricular dysfunction and symptoms of advanced heart failure. The risks 
and benefits of surgery must be carefully considered before proceeding, 
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however. In a fairly young patient, this may not be such a complicated issue, 
because the life expectancy of the patient usually overrides everything else. It is 
a very different matter when the patient is an 87-year-old woman, as in the case 
reported twice in the New England Journal of Medicine under the titles "Too old 
54 60 
for what" and "You're never too old". This particular patient had "severe 
aortic stenosis, three vessel coronary artery disease, depressed left ventricular 
function, and moderately severe heart failure". The life expectancy of this 
woman, who happened to be healthy and vigorous, was 5 years. On the other 
hand, that of patients with AS and congestive heart failure together is < 2 
60 
years . From these numbers, it appears that she clearly could benefit from 
surgery. However, one needs to keep in mind that aside from the benefits, valve 
replacement in the elderly is associated with high mortality and morbidity 
23 
rates. This woman's operative risk was 8 to 10 percent or even higher, but her 
doctor felt that the risk was worth taking because surgery would improve her life 
tremendously. After all, in patients her age, the primary aim of surgery is to 
54 
improve the quality of life rather than prolonging it. 
Seven studies of AS patients, between 1934 and 1960, whose mean age 
was 61, showed a life expectancy of 2 years after onset of dyspnea, giving a 
50 
mortality rate of 49% per year. More recent studies of 45 patients with a mean 
age of 59, aortic stenosis, and congestive heart failure, showed a mortality rate of 
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54% per year. These patients either declined surgery or the risks were 
15 
considered to be much too high. In contrast, four studies of 157 octogenarians 
23 
(mean age, 82) who had successful aortic valve replacement and three studies 
of 51 octogenarians (mean age, 82) who survived aortic valve replacement and 
23 60 
coronary bypass surgery demonstrated a mortality rate of 0.4% per year. In 
cases of severe AS, it seems that "you're never too old". Even for the older 
60 
patients, aortic valve replacement may provide substantial benefits. 
Doppler echocardiography has allowed physicians to follow patients so 
that the optimal time for surgical intervention can be determined before damages 
to the left ventricle become irreversible or before cardiac events of any 
6 
significance have occurred. We must mention that a symptomless case of AS 
does not exclude the possibility of surgery. In fact, progressive valvular 
dysfunction and dilation, even in the absence of symptoms, may indicate the 
6 
need for surgery. 
G. RATE OF PROGRESSION OF THE DISEASE 
Aortic stenosis is a slowly progressive disease. Therefore, for years, there 
may be no or only minimal symptoms. As the disease worsens, many 
hemodynamic and structural changes take place such as: progressive increase in 

transvalvular gradients and hypertrophy of the left ventricle, resulting in 
6 
decreased systolic and diastolic functions along with ventricular dilation. Also 
seen in the late stage of AS are: abnormal ventricular filling, mitral regurgitation 
6 
and symptoms of heart failure, syncope or angina. Brener et al. did serial 
Doppler echoes on 394 consecutive patients with valvular AS at baseline and 
after a period of 37 ± 16 months and reported that increasing wall thickness is an 
adaptive mechanism that allows the ventricle to eject blood against an increased 
gradient, created by the stenosis, by building up a higher intracavitary pressure. 
This increase in wall thickness permits preservation of ventricular size. In others, 
however, mitral regurgitation ensues due to loss of forward output when the 
ventricle dilates.^ The reasons why these variations exist are not well 
understood. There is a limit to the adaptive nature of left ventricular wall 
hypertrophy. In fact, it may reach a point where the systolic wall stress is so high 
that it reduces the ejection fraction. The defect in fiber shortening is not a result 
of "intrinsic muscle dysfunction", but rather that of a "mismatch” between the 
6 
amount of thickening and the "increased afterload". Furthermore, Brener et al. 
found no correlation between systolic dysfunction and AS progression though 
they found increases in mitral regurgitation and systolic dysfunction to be very 
well correlated. This finding may be explained by the possibility of systolic 
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dysfunction being masked by the increasing mitral regurgitation which decreases 
the fluid volume of the left ventricle. 
On the average, aortic stenosis, measured by aortic valve area, progresses 
, 6 47 
predictably at a rate of about 0.14 cnr per year. Peter et al. analyzed the rate 
of progression of aortic valve gradient and of fractional shortening-velocity ratio 
in 49 patients and reported a median rate of progression of 7.2 mmHg per year. 
They also found that rapid progression (>10 mmHg/yr) was more prevalent in 
AS patients with coronary artery disease. Moreover, aortic regurgitation, 
documented at the time of the first catheterization, was associated with greater 
rates of progression. Even though there is strong statistical correlation between 
rapid rate of progression and valve calcification, valve regurgitation and 
coronary artery disease, most of the variability in the rate of progression remains 
17 
unexplained, as shown by the low correlation coefficients (0.3-0.4). 
35 
One study, which looked at congenital aortic valve stenosis, reported 
that patients who presented with mild stenosis had a much better prognosis than 
those with a moderate stenosis. Although congenital AS is mostly mild at 
presentation, fewer than 20% of the patients will have mild stenosis 30 years 




At this point, it remains a problem to predict the likelihood or rate of 
progression of AS in patients who present with mild or moderate disease. It is, 
however, a problem which may have irreversible consequences for patients if the 
risks are underestimated. Therefore, it is a matter which requires consideration, 
and Doppler echocardiography may just be the tool that holds the answer to this 
important question. 
III. STUDY QUESTIONS 
What is the rate of progression of AS in our veteran population? What are 
the factors which can help predict the rate of progression of AS? 
IV. METHODS 
A. PATIENT POPULATION 
A group of 109 patients were selected from Dr. Ira Cohen's database at the 
West Haven Veteran Medical Center. They were all patients with varying 
degrees of aortic stenosis who had had at least one echocardiogram within the 
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previous 18 months. They ranged in age from 44 to 97 with an average of 71 
(median=72, mode=73). Patients were reviewed both retrospectively and 
prospectively from the time of ascertainment. Data was collected from their echo 
charts, their medical charts, and their computerized lab values. 
Two groups of patients were analyzed. To evaluate the progression of the 
disease, the first group included only those patients who had more than one 
measure of the area of the aortic valve (AVA). Of the 109 patients originally 
identified, only 32 fit that criterion. Their ages ranged from 58 to 87 years and 
averaged 74.25 (median=75, mode=77). 
The second group included patients based on their peak aortoventricular 
gradient (pk AV gd), and only those who had more than one value for that 
parameter qualified. Of the 109 patients, 69 met that criterion and their ages 
ranged from 51 to 86 with an average of 72 (median=73, mode=77). 
B. DATA ANALYSIS 
1. AVA Group 
For each of the 32 patients in that group, we graphed the area of the aortic 
valve and subgrouped them based on whether they had a decrease (defined as 
"any decrease"), or an increase or no change in the AVA. We used an unpaired 
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t-test to determine whether the duration of observation was comparable in those 
two subgroups. Each subgroup was then characterized according to the 
following risk factors: age, history of hypertension (HTN), smoking, cholesterol 
level (chol) > 200. HDL < 29, triglyceride (trig) > 160, non insulin-dependent 
diabetes mellitus (NIDDM), insulin-dependent diabetes mellitus (IDDM), blood 
urea nitrogen (BUN), and creatinine (Cr) > 2. 
For each of the above 9 risk factors, the patients with decrease in the AVA 
were further divided according to the presence or the absence of that factor. The 
mean AVA decrease and one standard deviation (1 SD) were calculated. A 
paired t-test was used on each group of patients with a particular risk factor and 
p values determined to establish any significance. In addition, those patients 
were also divided according to the number of risk factors present and again, 
mean AVA decreases were calculated, paired t-tests were used and p values 
were determined. Furthermore, looking at all patients with AVA decrease, 
correlation coefficients were calculated for each individual risk factor and for the 
number of risk factors present. 
Fastly, we ran a multiple regression analysis on all the thirty-two patients 
in order to determine the collective effect of the nine risk factors studied. 
2. Peak AV Gradient Group 

Considering the 69 patients in that group, the same analyses were carried 
out as for the AVA group, with the exception of the multiple regression analysis. 
The other difference was that patients were subgrouped based on whether they 
had an increase (defined as "any increase"), or a decrease or no change in the 
peak AV gradient (pk AV gd). 
V. RESULTS 
A. AVA GROUP 
Of the 32 patients included in this group, 21 (65.6%) were found to have a 
decrease in the AVA, indicating progression of the stenosis (subgroup A), while 
the remaining 11 had either an increase or no change (subgroup B). The average 
duration of observation was 15 months ±6(1 SD) for the former subgroup and 16 
months ±6(1 SD) for the latter. 
Patients in subgroup A had an average age of 74 (range=62-87). In 
addition, 67% were hypertensive, 43% smoke, 33% had a cholesterol level > 200, 
10% had an HDL < 28, 29% had a triglyceride level > 160, 10% had NIDDM, 5% 
had IDDM, 14% had BUN > 40, and another 14% had a creatinine > 2 (Table 1). 
On the other hand, subgroup B showed the following characteristics : average 
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age of 74.5 (range=58-83), 82% with a history of HTN, 73% positive for smoking, 
64% with cholesterol > 200, 0% with HDL < 28, 9% with triglyceride > 160, 9% 
with NIDDM, 0% with IDDM, 18% with BUN > 40, and 18% with creatinine > 2 
(Table 1). 
Patients in subgroup A had an overall mean AVA decrease of 0.35 cm2 ± 
0.17 (1 SD), equivalent to 0.35 cm2/year ± 0.22 (1 SD), while those in subgroup B 
had an overall mean AVA increase of 0.34 cm2 ± 0.33 (1 SD). The presence of 
HTN, smoking, chol > 200, trig > 160 and NIDDM was associated with a greater 
mean AVA decrease (Table 2). 
The two-tailed t values were all very small and the p values not significant 
(Table 3). Except for HTN which had a correlation coefficient of 0.51 (although 
still under 0.6 which is usually considered significant), all the other risk factors 
studied had very low coefficients, ranging from -0.27 to +0.26 (Table 3). 
Results were similar when patients were grouped according to the 
number of risk factors present, the most being 5 and the least 0. All two-tailed t 
values were very small, leading to insignificant p values, and correlation 
coefficients ranged from -0.53 to +0.50. Those two extreme coefficients 
correspond to the absence of all risk factors and the presence of 2 risk factors, 
respectively (Table 4). Lastly, patients with 2 risk factors seemed to have the 
greatest mean AVA decrease (Table 9). 
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The multiple regression analysis yielded a collective correlation coefficient 
of 0.363 when all nine factors were studied simultaneously, for a corresponding 
insignificant p value of 0.887. When the effect of each risk factor was 
investigated separately, a triglyceride level > 160 was found to have the greatest 
correlation coefficient (0.246). However, the corresponding p value was not 
significant (p=0.174). Moreover, the total number of risk factors appeared to 
have an inverse correlation with disease progression (Coefficient=-0.019). 
B. PEAK AV GRADIENT GROUP 
That group comprised 69 patients, 58 of whom were found to have an 
increase in the peak aortoventricular gradient (subgroup C) while the remaining 
11 had either a decrease or no change (subgroup D). The former had an average 
study time of 4.6 years ±2(1 SD) and the latter of 2.7 years ± 1.9 (1 SD). 
The mean age of patients in subgroup C was 72 (range=51-86) compared 
to 74 (range=59-83) in subgroup D. Furthermore, subgroup C was characterized 
by 71% HTN, 52% smoking, 48% chol > 200, 7% HDL < 28, 21% trig > 160, 10% 
NIDDM, 7% IDDM, 14% BUN > 40, and 14% Cr > 2. The percentages for 




The overall average increase in the pk AV gd was 22 mmHg ± 2.39 (1 SD) 
(6 mmHg/year ± 5.5 [1 SD]) in subgroup C but the average decrease was only 5 
mmHg ± 1.90 (1 SD) in subgroup D. A history of HTN and the presence of 
NIDDM were the only 2 factors associated with a higher pk AV gd increase 
when compared with the groups in which they were absent (Table 6). 
Similar to the analysis of the AVA group, the two-tailed t values 
calculated for each risk factor taken separately were very small and the 
corresponding p values very high (p=NS in all groups). In addition, the 
correlation coefficients were also very low, ranging from -0.17 to +0.19 (Table 7). 
Finally, the analysis of groups based on the number of risk factors present 
again yielded results similar to those of the AVA. In that group, the most risk 
factors present simultaneously in any one patient was 6 and the least 0. The two- 
tailed t values were extremely small and the p values failed to show significance. 
The correlation coefficients also were low, with a very narrow range (from -0.09 
to +0.12) (Table 8). Furthermore, the presence of 6 risk factors appeared to be 
associated with the largest mean pk AV gd increase as shown in table 10. 
VI. DISCUSSION 
A. MAJOR FINDINGS 
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This study found a mean rate of progression of aortic stenosis of 0.35 
2 
cm /year ± 0.22 (1 SD). Twenty one out of thirty two patients experienced 
progression during the mean 15 month ± 6 (1 SD) observation period. The 
9 
greatest average AVA decrease, 0.48 cm /year ± 0.21 (1 SD), was associated with 
the simultaneous presence of 2 risk factors (any 2 factors). 
We found a mean peak AV gradient increase of 6 mmHg/year ± 5.5 (1 
SD). Over the average course of 4.6 years ± 2 (1 SD), increase in transvalvular 
gradient was observed in fifty eight of the sixty nine patients in that group. 
Lastly, the greatest mean increase, 8.1 mmHg/year ± 7.7 (1 SD), was seen in 
association with 4 risk factors simultaneously present. 
B. AVA GROUP 
1. Overall Results 
Twenty one (subgroup A) out of the 32 patients in that group were found 
2 
to have a progression of their stenosis, which averaged 0.35 cm ± 0.17 (1 SD) 
over a mean 15 month period ± 6 (1 SD) (0.35 cm“/year ± 0.22 [1 SD]). All the 9 
risk factors studied were present in subgroup A as opposed to 7 (HDL<29 and 
IDDM were absent)) in the remaining 11 patients (subgroup B). Only HDL < 29, 
trig > 160, NIDDM and IDDM were present in a greater percentage of patients in 
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the former subgroup, compared to the latter (Table 1). Within subgroup A, the 
presence of a history of HTN, smoking, Choi > 200, trig > 160, NIDDM, and any 
2 risk factors were found to be associated with a greater progression of AS as 
measured by the average decrease in the AVA (Tables 2 and 9). Finally, using 
two-tailed paired t-tests and correlation coefficients, none of the 9 factors was 
found to be significantly correlated with disease progression (Table 3). Neither 
were the number of risk factors present simultaneously in any given patient 
(Table 4). 
2. Individual Risk Factors 
a. History of HTN 
This risk factor was not found to be significantly associated with 
disease progression, though with a correlation coefficient of 0.51, it had the best 
32 
association (Table 3). Floagland et al. also demonstrated this lack of 
significance. Flowever, these results are not consistent with those of the Helsinki 
Ageing Study (discussed in the introduction of this paper) which showed HTN 
to be significantly associated with AS7L It must be emphasized that both our 
study and the one by Hoagland et al. are small studies (32 and 105 patients 
respectively) based on selected groups, while the Helsinki study was larger (577 




Smoking was second only to HTN as far as the strength of its 
correlation with AS progression (coefficients.26). However, that correlation 
was not significant. (Table 3). The absence of statistical significance was also 
32 38 
demonstrated by Hoagland et al., “ as well as the Helsinki Ageing Study/ 
c. Serum Lipids 
We found no statistical significance in the association between any 
of the lipids and AS progression (Table 3). These results are compatible with 
32 
those reported by Hoagland et al. ^ and by Lindroos in the Helsinki Ageing 
38 
Study. However, they differ from those of Deutscher et al. who found an age- 
dependent association between hypercholesterolemia, defined as a chol > 300 
21 
mg/ml, and "calcific aortic stenosis". In this study, we used 200 as the cut-off 
value instead of 300, a choice which should increase the strength or the 
magnitude of the association rather than the reverse. The Deutscher et al. study 
was smaller than the ones mentioned above, with only 54 patients and included 
very selected patients. 
d. Diabetes 
Statistically, neither NIDDM nor IDDM was found to be 
32 
significantly associated with AS progression (Table 3). Hoagland et al. “ and 
38 
Lindroos found similar results. On the other hand, in the same study that 
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looked at hypercholesterolemia, Deutscher et al. found diabetes to be associated 
21 
with AS in an age-dependent fashion. However, as we have mentioned above, 
that study was very small and selective (54 patients with AS), especially 
38 
compared to the Helsinki study (577 unselected patients)."1 
C. PEAK AV GRADIENT GROUP 
1. Overall Results 
Of the 69 patients in that group, 58 (84%) (subgroup C) experienced 
increase in the peak gradient across their aortic valve, the mean being 22 mmHg 
± 2.39 (1 SD) over the course of an average of 4.6 years ±2(1 SD) (6 mmHg/year 
± 5.5 [1 SD]). As with the AVA group, all 9 risk factors were present in subgroup 
C, compared with 7 (HDL<29 and IDDM absent) in subgroup D (the 11 patients 
who did not experience increase). A greater percentage of patients in subgroup 
C had the following risk factors: smoking, HDL < 29, NIDDM, IDDM and BUN > 
40 (Table 5). Within subgroup C, only a history of HTN and NIDDM were found 
to be associated with a greater average increase in the gradient (Table 6). So 
were the presence of 2 and 4 risk factors simultaneously (Only one patient in that 
group had 6 risk factors and that value, although the largest, is therefore not 
reliable) (Table 10). Lastly, none of the 9 risk factors was significantly correlated 
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with pk AV gd increase, as assessed by two-tailed paired t-tests and correlation 
coefficients (Table 7). That was also true of the number of risk factors present 
simultaneously in a patient (Table 8). 
D. RATE OF PROGRESSION 
Based on measurements of the aortic valve area, this study found an 
average rate of AS progression of 0.35 cnr/year ± 0.22 (1 SD), a rate more than 
twice as fast as the 0.14 cm2/year quoted in the literature. Based on the gradient 
across the valve, it was found to be 6 mmHg/year ± 5.5 (1 SD), compared to 7.2 
47 6 
mmHg/year and 8.3 mmHg/year as reported by Peter et al. and Brener et al., 
respectively. 
While the progressive nature of aortic stenosis has been consistently 
demonstrated among patients, the rate at which it progresses remains highly 
variable between patients. Factors that have been associated with a greater rate 
2 13 57 
of progression (i.e., >0.15 cm“/year) are: degenerative-calcific AS, ' initial 
mild degree of As/'14,4'- presence and extent of valve calcification/^ aortic 
regurgitation (AR) 1 (those two being specifically associated with a greater 




reduced cardiac output/ progressive left ventricular hypertrophy (LVH), and 
17 47 
symptomatic or angiographic evidence of coronary artery disease (CAD). ' 
All of the 21 patients who experienced disease progression had 
"degenerative-calcific" AS since none of them was noted to have an abnormal 
aortic valve structure on echocardiography. Only 3 of the 21 had mild AS at the 
beginning of the observation period (p=NS); the others had either moderate (16 
patients) or severe (2 patients) AS. Valve calcification, however, was present in 
all of them in either a moderate (12 patients) or a severe (9 patients) form. 
Sixteen of the 21 patients had aortic regurgitation (10 mild, 3 moderate, and 3 
severe) (p=NS), while 11 of them had mitral regurgitation (7 mild and 4 
moderate) (p=NS). Cardiac output was not calculated directly. However, since 
progressive impairment of systolic function can lead to reduction in cardiac 
output (CO), we can look at systolic function in lieu of CO. Among the 21 
patients with progression, only 6 had impaired systolic function (p=NS) while 14 
showed progressive LVH (p=NS). Coronary artery disease was not looked at in 
this study. 
Of those 8 factors reported in the literature as having an association with a 
greater rate of AS progression, 7 were looked at in this study. Two of them 
("degenerative-calcific stenosis" and AV calcification) were present in all 21 
patients with AS progression. Another three (MR, progressive LVH, and AR) 
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were present in a greater number of patients. The remaining two (initial mild AS 
and impaired LV function) were not found to be more prevalent in this group. 
All p values failed to show any statistical significance. 
On the other hand, since aortic valve calcification and aortic regurgitation 
(AR) have been found to be associated with a greater increase in peak AV 
18 
gradient across the valve, ‘ we looked at the prevalence of those two factors in 
the peak AV gradient group. Valve calcification was present in all 58 patients in 
that group (5 mild, 25 moderate, and 28 severe), while AR was observed in 30 of 
them (18 mild, 9 moderate, and 3 severe) (p=NS). Despite these high 
prevalences, the average peak AV gradient increase in this study was only 6 
47 6 
mmHg/year ± 5.5 (1 SD), compared to 7.2 mmHg and 8.3 mmHg previously 
reported. This value was also much lower than the one quoted by Davies et al. 
who found the presence and extent of valve calcification to be associated with a 
greater rate of increase in pressure gradient (9.7 mmHg/year vs 4.4 
mmHg/year). ^ 
E. LIMITATIONS 
1. Reliability of measuring valve area and gradient 
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The valve area is a calculated number. It is calculated by the continuity 
equation when Doppler echocardiography is used, and by the Gorlin equation 
when invasive techniques are used. However, both of those equations are 
dependent on the transvalvular volume flow rate. Therefore, valve area 
measurements may be difficult to interpret in the setting of reduced 
9 
transvalvular flow associated with left ventricular dysfunction. 
Of the 21 patients in the subgroup with AVA decrease, 6 had TV 
dysfunction. Analysis of only those with preserved TV function, however, did 
not yield different results. The average AVA decrease was 0.35 cm2/year ± 0.18 
(1 SD), compared to the 0.35 cnr/year ± 0.22 (1 SD). Furthermore, the 6 patients 
with TV dysfunction experienced a negligibly lesser decrease (0.34 
cm2/year±0.32 [1 SD] ) (p=NS). 
The gradient across the valve is dependent upon two factors: the area of 
the valve and the ventricular function. In other words, adequate flow is needed, 
together with a reduced aortic valve area in order to establish a gradient. Thus, 
even in the presence of a stenotic aortic valve, the gradient may not be 
comparatively elevated if ventricular function is reduced. 
Of the 58 patients who experienced a decrease in their peak AV gradient, 
10 had ventricular dysfunction. However, they constitute a small percentage of 
the whole group (17%) and they should not affect the study results overall 
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Therefore, the 6 mmHg/year± 5.5 (1 SD) mean increase should be close to the 
actual increase. When the analysis was repeated for the 48 patients with 
preserved LV function, the average peak AV gradient increase was found to be 
6.7 mmHg/year ± 5.9 (1 SD), compared to 3.9 mmHg/year ± 2.1 (1 SD) for the 10 
patients with LV dysfunction (p=NS). 
2. Sample size 
Although we started out with a sample of 109 patients, we were able to 
include only thirty-two in the analysis which looked at decreases in the area 
under the aortic valve as indicators of disease progression. This limitation is a 
direct result of the largely retrospective nature of our study, since we could not 
make sure that the proper measurements were taken during the 
echocardiograms or that the specific information was asked during history¬ 
taking. 
The statistical power of our sample was, therefore, presumed low at the 
onset. Indeed, it was calculated for each of the tests performed and found 
consistently to be very low. The small sample was even more inappropriate for 
the multiple regression analysis, especially since we looked at a total of nine 
factors. Generally, the more factors under consideration, the more patients 
needed in order to be able to dissociate the effects of one from another. In fact, 
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our sample is so small that many would even argue against the use of such 
analysis. Consequently, it is not surprising that our analyses yielded non 
significant results. 
In light of this limitation, we can not conclude that the nine factors 
investigated in this study are not statistically significantly associated with aortic 
stenosis progression. They did not seem to be, based on our results. However, 
even if they had appeared to be, our sample has such low statistical power, that 
we would have had to question the validity of such results. Larger studies are 
therefore needed. 

VII. TABLES AND FIGURE 42 
TABLE A 
Effect of diabetes upon risk of aortic stenosis. 
according to aae group 
Aortic stenosis cases Controls 
Total no. No. with Total no. No. with Odds P 
Age of patients diabetes of patients diabetes ratio value 
<50 8 1 (12.5%) 102 12(1 1 .8%) 1 .07 NS* 
50-59 20 7(35.0%) 256 37(14.4%) 3.20 <0.05’ 
60 25 7(28.0%) 1 03 16(15.5%) 2.11 NS* 
Age groups 
50-59 and 45 14(31.1%) 359 53(14.8%) 2.62f <0.01 
60 combined (1.17-5.53)§ 
* Statistical significance of difference from unity based on Mantel-Haenszel chi-square statistic for single 
stratum. 
t Mantel-Haenszel age adjusted summary odds ratio. 
Mantel-Haenszel chi-square statistic for testing overall association: 7.514 
§ 95% confidence interval. 




Effect of hypercholesterolemia upon risk of aortic stenosis. 
according to aae group 
Aortic stenosis cases Controls 
No. with No. with 
Total no. cholesterol Total no. cholesterol Odds P 
Age of patients 300 mg of patients 300 mg ratio value 
<50 7 0 1 02 17(16.7%) NS* 
50-59 1 9 6(31.6%) 253 29(1 1.5%) 3.61 <0.02* 
60 25 6(24.0%) 98 12(12.2%) 2.26 NS* 
Age groups 
50-59 and 44 12(27.3%) 351 41(11.7%) 2.75f <0.01 
60 combined (1.20-6.39)§ 
* Statistical significance of difference from unity based on Mantel-Haenszel chi-square statistic for single 
stratum 
t Mantel-Haenszel age adjusted summary odds ratio. 
Mantel-Haenszel chi-square statistic for testing overall association: 7.510. 
§ 95% confidence interval. 





Changes of echocardiographic parameters during follow-up in 
two patients with severe aortic stenosis but normal left ventri¬ 
cular wall thickness. Top left: left ventricular end-diastolic dia¬ 
meter (LVEDD), top right: left ventricular fractional shortening 
(FS), bottom left: mean wall thickness at end diastole, bottom right: 
aortic area calculated according to the continuity equation by 
Doppler. Patient 1 is indicated by open squares and patient 2 by 
open circles. 




Comparison between patients with decrease in AVA and those 
without decrease, according to risk factors 
Subgroup A 1 Subgroup B 2 
(21 patients) (11 patients) t values p values 
Risk factors # (%) # (%) 
HIST. OF HTN 14 (67) 9 (82) 0.409 NS 
SMOKING 9 (43) 8 (73) 0.231 NS 
CHOL>200 7 (33) 7 (64) 0.4 NS 
HDL<29 2 (9.5) 0 (0) § § 
TRIG>160 6 (29) 1 (9) § § 
NIDDM 2 (9.5) 1 (9) § § 
IDDM 1 (5) 0 (0) § § 
BUN>40 3 (14) 2 (18) 0.21 9 NS 
CREAT>2 3 (14) 2 (18) 0.219 NS 
Age 
Distribution 
AVERAGE 74 74.5 
MEDIAN 75 75.5 
MODE 77 8 1 
RANGE 62-87 58-83 
1 Patients with AVA decrease 
2 Patients with either AVA increase or no change 




Mean AVA decrease in patients, according to presence 
or absence of risk factors 
Risk factors Present Absent t values p values 
HIST. OF HTN 0.41 +/- 0.14 0.23 +/- 0.18 0.102 NS 
SMOKING 0.40 +/- 0.18 0.28 +/- 0.16 0.1 82 NS 
CHOL>200 0.40 +/- 0.16 0.32 +/- 0.18 0.359 NS 
HDL<29 0.28 +/- 0.18 0.36 +/- 0.17 0.53 NS 






NIDDM 0.45 +/- 0.07 0.34 +/- 0.18 0.654 NS 
IDDM 0 .15 * 0.36 +/- 0.17 § § 
BUN>40 0.33 +/- 0.21 0.35 +/- 0.17 0.861 NS 
CREAT>2 0.33 +/- 0.21 0.35 =/- 0.17 0.861 NS 
Includes only one patient 
§ Not applicable 

TABLE 3 
Two-tailed t values, p values and correlation 
coefficients in patients with AVA decrease. 
according to risk factors 
Risk factors t values p values Corr. Coeff. # patients 
HIST, of HTN 4.331 E-0.8 NS 0.51 1 4 
SMOKING 0.0002 NS 0.26 9 
CHOL>200 0.001 NS 0.21 7 
HDL<29 0.272 NS -0.17 2 
TRIG>160 0.003 NS 0.13 6 
NIDDM 0.07 NS 0.21 2 
IDDM * * -0.27 1 
BUN>40 0.109 NS -0.04 3 
CREAT>2 0.109 NS -0.04 3 




Two-tailed t values, p values and correlation 
coefficients in patients with AVA decrease- 
according to the number of risk factors 
# risk factors t values p values Corr. Coeff. # patients 
5 0.374 NS -0.1 2 
4 0.07 NS 0.19 2 
3 0.003 NS 0.07 5 
2 0.0002 NS 0.5 6 
1 0.1 18 NS -0.28 3 
0 0.05 NS -0.53 3 




Comparison between patients with increase in ok AV ad & those 
without, according to risk factors 
Subgroup C 1 Subgroup D2 
(58 patients) (11 patients) t values p values 
Risk factors # (%) # (%) 
HIST. OF HTN 41 (71) 8 (72) 0.634 NS 
SMOKING 30 (52) 5 (45) 0.61 5 NS 
CHOI_>200 28 (48) 6 (55) 0.795 NS 
HDL<29 4 (7) 0 (0) § § 
TRIG>160 12 (21) 6 (55) 0.4 NS 
NIDDM 6 (10) 1 (9) § § 
IDDM 4 (7) 0 (0) § § 
BUN>40 8 (14) 1 (9) § § 
CREAT>2 8 (14) 3 (27) 0.28 NS 
Age 
Distribution 
Average 72 74 
Median 72 74 
Mode 70 75 
Range 51-86 59-83 
1 Patients with pk AV gd increase 
2 Patients with either pk Av gd decrease or no change 




Mean PK AV GD increase in patients, according to presence 
or absence of risk factors 
Risk factors Present Absent t values p values 
HIST. OF HTN 23 mmHg +/- 16 16 mmHg +/- 12 0.27 NS 
SMOKING 24 mmHg +/- 17 25 mmHg +/- 26 0.409 Ns 
CHOL>200 20 mmHg +/- 16 24 mmHg +/- 13 0.13 NS 
HDL<29 22 mmHg +/- 19 22 mmHg +/- 14 1 NS 
TRIG>160 22 mmHg +/- 14 22 mmHg +/- 15 1 NS 
NIDDM 25 mmHg +/- 29 21 mmHG +/- 12 0.62 NS 
IDDM 20 mmHg +/- 15 22 mmHg +/- 15 0.76 NS 
BUN>40 20 mmHg +/- 13 22 mmHg +/- 15 0.76 NS 




Two-tailed t values, p values and correlation coefficients 
in patients with ok AV ad increase. 
according to risk factors 
Risk factors t values p values Corr. Coeff. # patients 
HIST, of HTN 1.341 E-11 NS 0.19 4 1 
SMOKING 3.354 E-08 NS 0.13 30 
CHOL>200 3.315 E-07 NS -0.14 28 
HDL<29 0.107 NS 0.001 4 
TRIG>160 0.0003 NS -0.001 1 2 
NIDDM 0.094 NS 0.07 6 
IDDM 0.081 NS -0.04 4 
BUN>40 0.004 NS -0.04 8 
CREAT>2 0.005 NS -0.17 8 

TABLE 8 
Two-tailed t values, p values and correlation coefficients 
in patients with ok AV ad increase, according 
to the number of risk factors 
# risk factors t values p values Corr. Coeff. # patients 
6 ★ * 0.12 1 
5 0.162 NS -0.09 4 
4 0.002 NS 0.1 9 
3 3.793 E-06 NS -0.08 1 6 
2 0.001 NS 0.12 1 1 
1 0.0001 NS -0.04 9 
0 2.4 E-05 NS -0.04 8 
Total = 58 




Mean AVA decrease in patients, according to the 
number of risk factors present 






0.3 +/- 0.28 
0.45 +/- 0.07 
0.37 +/- 0.13 
0.48 +/- 0.12 
0 
0.23 +/- 0.15 
0.13 +/- 0.06 

TABLE 10 
Mean PK AV GD increase in patients, according to the 
number of risk factors present 
# risk factors Mean pk AV gd increase 
6 35 * 
5 17 +/- 18 
4 25 +/- 23 
3 19 +/- 11 
2 25 +/- 19 
1 20 +/- 9 
0 20 +/- 6 
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